Latigo Biotherapeutics reports 2Q loss per share of $27.59
Latigo Biotherapeutics said it posted a 2Q loss of $27.59 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.